SEC Form SC 13G/A filed by Entera Bio Ltd. (Amendment)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

(1) Gakasa Holdings, LLC holds 3,534,275 shares of common stock and 347,604 pre-funded warrants.

(1) Gakasa Holdings, LLC holds 3,534,275 shares of common stock and 347,604 pre-funded warrants.

(1) Gakasa Holdings, LLC holds 3,534,275 shares of common stock and 347,604 pre-funded warrants.

Entera Bio LTD. (the “Issuer”)

Kiryat Hadassa Minrav Building – Fifth Floor, Jerusalem 9112002, Israel

Knoll Capital Management LLC (“KCM”)

Fred Knoll (“Knoll”)

Gakasa Holdings, LLC. (“Gakasa”)

The principle business address for each of KCM, Knoll and Gakasa is 201 S. Biscayne Blvd suite 800, Miami, FL 33131

KCM is a limited liability company formed and existing under the laws of the State of Florida.

Knoll is a citizen of the United States.

Gakasa is a limited liability company organized under the laws of the State of Florida.

Ordinary Shares Nominal value of NIS 0.0000769 per share ("Ordinary Shares")

M40527109

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: _________________

Provide the following information regarding the aggregate number and percentage of class of securities of the issuer identified in Item 1. 

As of this filing: Gakasa beneficially owns 3,534,275 Shares of the Issuer’s Common Stock and 347,604 pre-funded warrants.. Each of KCM and Knoll beneficially own 3,534,275 Shares of the Issuer’s Common Stock and 347,604 pre-funded warrants.. KCM has trading authority for Gakasa, and Knoll is the President of KCM.

The shares of the Issuer’s Common Stock beneficially owned by each of Gakasa, KCM and Knoll constitute 9.967% of the Issuer’s Common Stock outstanding.

This percentage is calculated based on the expected 35,458,850 ordinary shares outstanding post financing close, as advised by the company.

KCM, Knoll and Gakasa share the power to vote or direct the vote of those shares of Common Stock owned by Gakasa.

KCM, Knoll and Gakasa share the power to dispose of or direct the disposition of those shares of Common Stock owned by Gakasa.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ¨.

Not Applicable.

Not Applicable.

Not Applicable.

Not Applicable

By Signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, I certify (the undersigned certifies) that the information set forth in this statement is true, complete and correct.